Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...
4don MSN
Exclusive: US FDA taps Merck drugs with blockbuster sales potential for national priority vouchers
The U.S. Food and Drug Administration is moving to fast-track reviews of two experimental Merck drugs with ...
A new FDA fast-track drug review program is increasingly allowing the White House and senior agency officials to influence which medicines are ...
The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten ...
The agency gave the green light to a U.S. company manufacturing Augmentin XR, an antibiotic first approved more than two ...
The tickets could go to the lipid-lowering pill enlicitide decanoate and the antibody-drug conjugate sacituzumab tirumotecan, though a spokesperson for the HHS did not confirm the news.
The FDA taps J&J drug teclistamab for its National Priority Voucher pilot, enabling expedited review for multiple myeloma treatment.
FDA grants 1st approval under priority voucher program to Augmentin XR, expediting review and supporting U.S. antibiotic supply chain resilience.
An FDA program to fast-track drug reviews has become a way for the White House to influence which medicines make their way fastest to patients ...
Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect ...
FDA has expanded its early alert pilot program to cover all medical devices, according to a September 29 notice. In November 2024, the FDA’s Center for Devices and Radiological Health launched the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results